Home » Topics » BioWorld Science, Hematologic

BioWorld Science, Hematologic
RSS

Antithrombotic P2T antagonists in development at Astra

March 8, 1999

Randomized comparison of aspirin, aspirin + warfarin and aspirin + ticlopidine following stenting

March 5, 1999

Platelet aggregation inhibitors in development at SmithKline Beecham

March 4, 1999

FDA grants priority review to Boehringer Ingelheim's new stroke therapy

March 4, 1999

Vasoflux is superior to other anticoagulants due to its unique mechanism of action

March 3, 1999

Corvas reacquires rights to injectable anticoagulant from Schering-Plough

March 2, 1999

Emisphere Technologies updates oral heparin development program

March 2, 1999

European CPMP recommends approval of Integrilin for acute coronary syndrome

March 1, 1999

Merck & Co.'s new thrombin inhibitors

March 1, 1999

Antiplatelet agents under research at Monsanto

March 1, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
Alicorn synthesizes new AAK1 inhibitors
BioWorld Science
Researchers from Alicorn Pharmaceutical Co. Ltd. and Jiangsu Alicorn Pharmaceutical Co. Ltd. have disclosed crystalline salts of compounds acting as...
CFTX-2034 successfully shows promise for post-bariatric hypoglycemia in preclinical research
BioWorld Science
Researchers from Confo Therapeutics NV presented the preclinical characterization of CFTX-2034, a selective somatostatin receptor subtype 5 (SSTR5) agonist...
Saniona reports preclinical data for SAN-2668
BioWorld Science
Saniona AB has presented preclinical data and its clinical development strategy for its lead clinical candidate, SAN-2668, which is a GABA-A receptor positive...
CC-3 antibody shows antitumoral activity in penile cancer
BioWorld Science
Advanced penile cancer (PeCa) is a rare cancer affecting the genitourinary tract with a 5-year survival rate of about 10% when metastatic. First-line therapies...